MGD-22

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameMGD-22
Drug Alias NameMGD-22
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionDNA-binding protein Ikaros degradersZinc finger protein helios degradersZinc finger protein Aiolos degraders
TargetsDNA-binding protein IkarosZinc finger protein heliosZinc finger protein Aiolos
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Institute of Pharmacology and ToxicologyNorth China University Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesNorth China University Of TechnologyBeijing Institute of Pharmacology and Toxicology
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A